Cargando…

Venous Thromboembolism in Japanese Patients With Pancreatic Cancer

OBJECTIVE: Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths in Japan. Previous studies from other countries have reported venous thromboembolism prevalence rates of 12 to 36% in patients with pancreatic cancer. In this study, we aimed to determine the inci...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suzuki, Takahito, Hori, Reina, Takeuchi, Kazutaka, Yamamura, Ryo, Katoh, Hiromasa, Noji, Yoshihiro, Yamaguchi, Masato, Fujino, Susumu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8573688/ https://www.ncbi.nlm.nih.gov/pubmed/34730013 http://dx.doi.org/10.1177/10760296211051766

Ejemplares similares

Venous Thromboembolism in Japanese Patients with Gynecologic Cancer
por: Suzuki, Takahito, et al.
Publicado: (2023)

Venous Thromboembolism in Patents With Lung Cancer
por: Suzuki, Takahito, et al.
Publicado: (2020)

Reduced Activity of Protein S in Plasma: A Risk Factor for Venous Thromboembolism in the Japanese Population
por: Jin, Xiuri, et al.
Publicado: (2021)

A Risk of Venous Thromboembolism Algorithm as a Predictor of Venous Thromboembolism in Patients with Colorectal Cancer
por: Chen, Ying, et al.
Publicado: (2021)

Possible risk factors for tip rupture of orbital atherectomy system
por: Katoh, Hiromasa, et al.
Publicado: (2021)

Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study
por: Tasaka, Nobutaka, et al.
Publicado: (2023)

Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism
por: Siddiqui, Fakiha, et al.
Publicado: (2022)

Venous and Arterial Thromboembolism in Patients with Metastatic Lung Cancer
por: Qin, Ya, et al.
Publicado: (2023)

Venous Thromboembolism in Patients with Cancer Receiving Specialist Palliative Care
por: Allende-Pérez, Silvia Rosa, et al.
Publicado: (2022)

Incidence and Clinical Features of Venous Thromboembolism in Inpatients with Mental Illness
por: Wang, Zibin, et al.
Publicado: (2023)

Hospital Variation and Associated Organizational Factors of Pregnancy-Related Venous Thromboembolism in China
por: Zhou, Qiongjie, et al.
Publicado: (2022)

Risk Factor Analysis of Postoperative Venous Thromboembolism in Patients After Thoracoscopic Lobectomy
por: Qiao, Junkai, et al.
Publicado: (2023)

Effect of Comorbidity Burden on the Risk of Venous Thromboembolic Events After Total Knee Arthroplasty
por: Bala, Abiram, et al.
Publicado: (2021)

Predictors of Venous Thromboembolism in Patients With Testicular Germ Cell Tumors: A Retrospective Study
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Multidisciplinary Bundle Approach in Venous Thromboembolism Prophylaxis in Patients with Non-Traumatic Subarachnoid Hemorrhage
por: Phan, Brian, et al.
Publicado: (2022)

Development and Validation of a Nomogram to Predict the Probability of Venous Thromboembolism in Patients with Epithelial Ovarian Cancer
por: Wang, Yuhan, et al.
Publicado: (2022)

Prevalence of Cancer in Patients with Venous Thromboembolism: A Retrospective Nationwide Case-Control Study in Sweden
por: Glise Sandblad, Katarina, et al.
Publicado: (2023)

Lymphocytes, Mean Platelet Volume, and Albumin in Critically Ill COVID-19 Patients with Venous Thromboembolism
por: Duan, Rundan, et al.
Publicado: (2023)

Derivation and External Validation of a Risk Assessment Model of Venous Thromboembolism in Hospitalized Chinese Patients
por: Chen, Xiaolan, et al.
Publicado: (2023)

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis
por: Lipardi, Concetta, et al.
Publicado: (2021)

Prediction and Diagnosis of Venous Thromboembolism Using Artificial Intelligence Approaches: A Systematic Review and Meta-Analysis
por: Wang, Qi, et al.
Publicado: (2021)

Prediction Model of in-Hospital Venous Thromboembolism in Chinese Adult Patients after Hernia Surgery: The CHAT Score
por: Gu, Zhi-Chun, et al.
Publicado: (2021)

Internal Validation of a Risk Scoring System for Venous Thromboembolism After Total hip or Knee Arthroplasty
por: Akamine, Akihiko, et al.
Publicado: (2022)

Anticoagulation Duration After First Venous Thromboembolism: Real-Life Data From the International, Observational WHITE Study
por: Palareti, Gualtiero, et al.
Publicado: (2021)

Predictive Value for Increased Red Blood Cell Distribution Width in Unprovoked Acute Venous Thromboembolism at the Emergency Department
por: Febra, Cláudia, et al.
Publicado: (2023)

Construction of Risk Assessment Model for Venous Thromboembolism After Colorectal Cancer Surgery: A Chinese Single-Center Study
por: Yao, Jianchang, et al.
Publicado: (2022)

The Application of the ThroLy Risk Assessment Model to Predict Venous Thromboembolism in Patients with Diffuse Large B-Cell Lymphoma
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

A Prospective Study Evaluating Patterns of Responses to the Caprini Score to Prevent Venous Thromboembolism After Interventional Treatment for Varicose Veins
por: Grill, Marcelo Halfen, et al.
Publicado: (2022)

Machine Learning to Dynamically Predict In-Hospital Venous Thromboembolism After Inguinal Hernia Surgery: Results From the CHAT-1 Study
por: Yan, Yi–Dan, et al.
Publicado: (2023)

Profile of Solid Tumor Patients Complicated With Venous Thromboembolism: A 10-Year Retrospective Cross-Sectional Study Based on 1482 Cases
por: Li, Huimin, et al.
Publicado: (2023)

Rivaroxaban Versus Low-Molecular-Weight Heparins in a Broad Cohort of Patients With Cancer-Associated Venous Thromboembolism: An Analysis of the OSCAR-US Program
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Combined Effect of MTHFR C677T and PAI-1 4G/5G Polymorphisms on the Risk of Venous Thromboembolism in Chinese Lung Cancer Patients
por: Wang, Baoyan, et al.
Publicado: (2021)

Plasminogen activator inhibitor-1, thrombin-antithrombin, and prothrombin fragment F1+2 have higher diagnostic values than D-dimer for venous thromboembolism after TKA
por: Yang, Yong, et al.
Publicado: (2022)

Warfarin Time in Therapeutic INR Range and Direct Oral Anticoagulant Adherence for Venous Thromboembolism Across the Spectrum of Weight and Body Mass Index: Findings from Veterans Health Administration
por: Din, Natasha, et al.
Publicado: (2023)

Incidence of venous thromboembolism in japanese trauma population
por: Miki, R, et al.
Publicado: (2015)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)

Real-World Analysis of Thromboembolic Events and Mortality of COVID-19 Outpatients in the United States
por: Peacock, W. Frank, et al.
Publicado: (2022)

Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy
por: Sun, Shuai, et al.
Publicado: (2022)

Predicting Perioperative Venous Thromboembolism in Japanese Gynecological Patients
por: Ikeda, Masae, et al.
Publicado: (2014)

The Role of Strain by Cardiac Magnetic Resonance Imaging in Predicting the Prognosis of Patients with Chronic Thromboembolic Pulmonary Hypertension
por: Zhang, Xuefei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2k8s0hgl11d7ts1eth643s8k6a